MicuRx Pharmaceuticals Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 166

Employees

  • Stock Symbol
  • 688373

Stock Symbol

  • Share Price
  • $0.76
  • (As of Friday Closing)

MicuRx Pharmaceuticals General Information

Description

Shanghai MicuRx Pharmaceutical Co Ltd is engaged in the discovery, development, and commercialization of inventive medicines for unmet clinical needs.

Contact Information

Website
www.micurxchina.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 53, Edison Road
  • Pudong New Area
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
SHG
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Number 53, Edison Road
  • Pudong New Area
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicuRx Pharmaceuticals Stock Performance

As of 13-Nov-2026, MicuRx Pharmaceuticals’s stock price is $0.76. Its current market cap is $498M with 656M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.76 $0.78 $0.60 - $1.07 $498M 656M 15.1M -$0.02

MicuRx Pharmaceuticals Financials Summary

As of 30-Sep-2026, MicuRx Pharmaceuticals has a trailing 12-month revenue of $24.4M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 560,903 548,969 383,616 484,285
Revenue 24,405 19,714 18,155 12,831
EBITDA (13,590) (30,603) (57,288) (55,486)
Net Income (13,910) (33,598) (61,421) (59,524)
Total Assets 88,012 100,774 116,317 164,851
Total Debt 50,834 54,258 41,350 31,204
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MicuRx Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MicuRx Pharmaceuticals‘s full profile, request access.

Request a free trial

MicuRx Pharmaceuticals Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

MicuRx Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4384185-A1 Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same Pending 23-Jun-2022
EP-4384527-A1 Prodrugs of boron compounds and their use in treating bacterial infections Pending 23-Jun-2022
WO-2021150792-A1 Novel compounds and composition for targeted therapy of kidney-associated cancers Inactive 21-Jan-2020
CA-2970546-A1 Antimicrobial polymyxins for treatment of bacterial infections Pending 16-Dec-2014
WO-2016100578-A2 Antimicrobial polymyxins for treatment of bacterial infections Inactive 16-Dec-2014 C07K7/52
To view MicuRx Pharmaceuticals’s complete patent history, request access »

MicuRx Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MicuRx Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MicuRx Pharmaceuticals‘s full profile, request access.

Request a free trial

MicuRx Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view MicuRx Pharmaceuticals’s complete esg history, request access »

MicuRx Pharmaceuticals FAQs

  • When was MicuRx Pharmaceuticals founded?

    MicuRx Pharmaceuticals was founded in 2007.

  • Where is MicuRx Pharmaceuticals headquartered?

    MicuRx Pharmaceuticals is headquartered in Shanghai, China.

  • What is the size of MicuRx Pharmaceuticals?

    MicuRx Pharmaceuticals has 166 total employees.

  • What industry is MicuRx Pharmaceuticals in?

    MicuRx Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is MicuRx Pharmaceuticals a private or public company?

    MicuRx Pharmaceuticals is a Public company.

  • What is MicuRx Pharmaceuticals’s stock symbol?

    The ticker symbol for MicuRx Pharmaceuticals is 688373.

  • What is the current stock price of MicuRx Pharmaceuticals?

    As of 13-Nov-2026 the stock price of MicuRx Pharmaceuticals is $0.76.

  • What is the current market cap of MicuRx Pharmaceuticals?

    The current market capitalization of MicuRx Pharmaceuticals is $498M.

  • What is MicuRx Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for MicuRx Pharmaceuticals is $24.4M.

  • What is MicuRx Pharmaceuticals’s annual earnings per share (EPS)?

    MicuRx Pharmaceuticals’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process